| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.44B | — | +39.3% |
| Cost of Revenue | $294.0M | — | +30.8% |
| R&D Expense | $422.0M | — | +12.7% |
| SG&A Expense | $209.0M | — | +75.4% |
| Operating Income | -$294.0M | — | -15.4% |
| Pre-tax Income | -$247.0M | — | -14.6% |
| Income Tax | $1.0M | — | +15.9% |
| Net Income | -$246.0M | — | -14.4% |
| EPS (Basic) | -$0.35 | — | -9.4% |
| EPS (Diluted) | -$0.35 | — | -9.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.19B | -1.4% | +2.5% |
| Short-term Investments | $2.01B | +8.7% | +26.8% |
| Accounts Receivable | $538.0M | -40.3% | +33.3% |
| Current Assets | $4.74B | -3.2% | +21.9% |
| Total Assets | $9.83B | +2.8% | +31.9% |
| Current Liabilities | $5.31B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $629.0M | — | +41.7% |
| Capital Expenditures | $33.0M | — | +90.0% |
| Investing Cash Flow | -$675.0M | — | -1812.7% |
| Financing Cash Flow | $31.0M | — | -15.1% |
| Free Cash Flow | $596.0M | — | +39.7% |
| +39.0% |
| Long-term Debt | $1.01B | -14.2% | +0.1% |
| Total Liabilities | $9.42B | +2.5% | +31.6% |
| Stockholders' Equity | $432.0M | +9.5% | +39.0% |